Azithromycin Injection
Brand names: Zithromax
Category: Anti-Infective
FDA status: To Be Discontinued · Last FDA update: Jan 20, 2026 · First posted: Jan 20, 2026 · 1 manufacturers, 1 listed presentations
As of Jan 20, 2026, the FDA lists Azithromycin Injection as being discontinued. Of 1 manufacturer presentations, 1 Not specified.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Zithromax IV, Injection, 500 mg/5 mL (NDC 0069-3150-83) NDC 0069-3150-83 |
Pfizer Inc. | Not specified | Discontinuation of the manufacture of the drug. |
Related medications in shortage
Other Anti-Infective medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Azithromycin Injection (FDA data as of Jan 20, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Azithromycin Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/azithromycin-injection.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).